Additional information
Description | Tauro-obeticholic acid, an active metabolite of obeticholic acid, functions as an agonist of the farnesoid X receptor (FXR) and is derived from chenodeoxycholic acid through semisynthesis [1]. It undergoes formation via taurine conjugation in the liver and can revert to obeticholic acid through enzymatic action by intestinal microflora. |
---|---|
Reference | [1] Markham, A., and Keam, S.J. Obeticholic acid: First global approval. Drugs 76(12), 1221-1226 (2016). |